  | Beguin, C., Kwan, O., Ritacco, C., Debray, J.-C., Dejardin, E., Dubois, S., Köse, M. C., Canti, L., Courtois, J., Seidel, L., Daulne, C., Caers, J., Beguin, Y., Ehx, G., & Baron, F. (17 November 2023). TNF-α priming of human regulatory T cells does not increase their ability to prevent xenogeneic graft-versus-host disease [Paper presentation]. Congrès annuel de la Société Francophone de Greffe de Moelle et Thérapie Cellulaire, Lille, France.  Peer reviewed |
 | Köse, M. C. (2023). Understanding Disease Progression and Target Identification for Multiple Myeloma [Doctoral thesis, ULiège - University of Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/306474 |
 | Ritacco, C., Köse, M. C., Courtois, J., Canti, L., Beguin, C., DUBOIS, S., Vandenhove, B., Servais, S., Caers, J., Beguin, Y., Ehx, G.* , & Baron, F.*. (17 March 2023). Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells. iScience, 26 (3), 106085. doi:10.1016/j.isci.2023.106085 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Gou, M.-J., Köse, M. C., Nix, C., Cobraiville, G., Caers, J., & Fillet, M. (01 February 2023). Complementarity of CZE-DTIMS-QTOF to microfluidic-RPLC-DTIMS-QTOF for multiple myeloma cells surface antigen discovery [Paper presentation]. CIRM Day, Liège, Belgium. Peer reviewed |
 | Köse, M. C., Lejeune, M., Gou, M.-J., Duray, E., Cobraiville, G., Gothot, A., Beguin, Y., Fillet, M., & Caers, J. (15 November 2022). Integrative Analysis of Proteomics and Transcriptomics Reveals the Etrb As Novel Single Target and New Combinatorial Targets for Multiple Myeloma [Paper presentation]. ASH 2022 Symposium, New orleans, United States. |
 | Gou, M.-J., Köse, M. C., Crommen, J., Nix, C., Cobraiville, G., Caers, J., & Fillet, M. (01 November 2022). Contribution of Capillary Zone Electrophoresis Hyphenated with Drift Tube Ion Mobility Mass Spectrometry as a Complementary Tool to Microfluidic Reversed Phase Liquid Chromatography for Antigen Discovery. International Journal of Molecular Sciences, 23 (21), 13350. doi:10.3390/ijms232113350 Peer Reviewed verified by ORBi |
Gou, M.-J., Köse, M. C., Cobraiville, G., Caers, J., & Fillet, M. (13 September 2022). Use of CE-IM-MS as a complementary tool to microfluidic-LC-IM-MS for cell surface antigen discovery [Paper presentation]. 39th International Symposium of Pharmaceutical and Biomedical analysis (PBA), Mons, Belgium. Peer reviewed |
 | Köse, M. C., Bergiers, I., Malfait, M., Heidrich, B., De Maeyer, D., FOURNEAU, N., Verbist, B., Van Houdt, J., Vanhoof, G., Verona, R., Delforge, M., Depaus, J., Meuleman, N., Van Droogenbroeck, J., Vlummens, P., Heuck, C. J., Bahlis, N., Caers, J., & Casneuf, T. (09 June 2022). S170: DYNAMIC INTERPLAY BETWEEN TUMOR AND MICRO-ENVIRONMENT DURING MYELOMA DISEASE PROGRESSION [Paper presentation]. EHA symposium, vienna, Austria. doi:10.1097/01.hs9.0000843572.19189.b6 |
 | Vrancken, L., Lejeune, M., PIROTTE, M., Duray, E., Köse, M. C., BEGUIN, Y., & CAERS, J. (2021). Le myélome multiple : un tour d’horizon des nouveautés dans sa biologie et son traitement. Revue Médicale de Liège, 76, 482-488. Peer reviewed |
 | Lejeune, M., Köse, M. C., Duray, E., Einsele, H., Beguin, Y., & Caers, J. (07 May 2020). Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies. Frontiers in Immunology, 11 (762), 1-20. doi:10.3389/fimmu.2020.00762 Peer Reviewed verified by ORBi |
 | Lejeune, M., Köse, M. C., Duray, E., Beguin, Y., & CAERS, J. (2020). Les anticorps bispécifiques ciblant les lymphocytes T dans le myélome multiple. OncoHemato : Revue Multidisciplinaire d'Oncologie et Hématologie, 14 (6), 30-34. Peer reviewed |
 | Bolomsky, A., Vogler, M., Köse, M. C., Heckman, C. A., Ehx, G., Ludwig, H., & Caers, J. (2020). MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents. Journal of hematology & oncology, 13 (1), 173. doi:10.1186/s13045-020-01007-9 Peer reviewed |